Cytonics Corporation
PrivateLast Round
Crowdfunding
Mar 25, 2025
Est. Valuation
$111.09M
Total Funding Raised
$29.8M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Cytonics Corporation operates in Healthcare & Life Sciences and is based in Jupiter, Florida. Its latest recorded funding round was a Crowdfunding round in March 2025.
Cytonics Corporation is a biotechnology company developing biologic therapies and diagnostics for musculoskeletal diseases such as osteoarthritis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cytonics Corporation Comparables
Compare Cytonics Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Doron Therapeutics | 78% | |
| 4Moving Biotech | 78% | |
| Paradigm Biopharmaceuticals Limited | 78% |
For institutional investors. Book with your work email.
Cytonics Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Mar 25, 2025 | ||||
| Series C | Apr 15, 2023 | ||||
| Series C | Nov 5, 2020 | ||||
| Series B | Jan 15, 2016 | ||||
| Corporate Funding | Feb 1, 2011 | ||||
Series A | Nov 30, 2009 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cytonics Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| StartEngine Crowdfunding | Crowdfunding, Series C |
| Johnson & Johnson Innovation - JJDC, Inc. | Series B |
| SeedInvest | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 486% MoM.
- Jun 22, 2026
Monthly visitors increased 40% MoM.
For institutional investors. Book with your work email.
Cytonics Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cytonics Corporation's valuation, stock price, and market status.
Is Cytonics Corporation a public or private company?
Cytonics Corporation is a private company.
What is the current stock price of Cytonics Corporation?
Cytonics Corporation is a private company, so its shares have no public market price. Caplight tracks Cytonics Corporation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cytonics Corporation worth (valuation)?
Cytonics Corporation's valuation is estimated at $111.1M based on funding round data.
Can I buy Cytonics Corporation stock?
Cytonics Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cytonics Corporation's last funding round?
Cytonics Corporation's most recent funding round was Crowdfunding on March 25, 2025.
Who are the main investors in Cytonics Corporation?
Key investors in Cytonics Corporation include NIH RADx, StartEngine Crowdfunding, Johnson & Johnson Innovation - JJDC, Inc., SeedInvest.
Will Cytonics Corporation IPO soon?
No public IPO plans have been announced for Cytonics Corporation.
How can I track Cytonics Corporation secondary market activity?
Caplight tracks bids, offers, and trades in Cytonics Corporation's shares on secondary markets.